Steven Feldman
Site Head & Scientific Director, Laboratory for Cell & Gene Medicine Stanford GMP Facility
Steven Feldman is Site Head and Scientific Director, Laboratory of Cell and Gene Medicine (Stanford GMP Facility) at Stanford University, where he leads process development and manufacturing supporting clinical translation of cell and gene therapy programs. He directs efforts developing novel cell and therapies for the treatment of cancer and rare diseases and advancing manufacturing of gammaretroviral and lentiviral vectors to support investigator-initiated clinical trials. His research focuses on development of retroviral and lentiviral packaging cell lines and large-scale closed cell culture processes to support production of clinical reagents. Dr. Feldman holds a Ph.D., Microbiology from University of California, Berkeley.
Seminars
- Transitioning from a viral to non-viral platform for a cell therapy
- Overexpression of genes to enhance CAR-T function using a non-viral strategy for pediatric rare disease
- Establishing strategic manufacturing processes early to ensure phase one clarity, reduced rework and a scalable foundation for future growth
- Identifying optimal opportunities to optimize processes to improve manufacturing and trial outcomes
- Collaborating with flexible manufacturing partners to embed long term strategy from the beginning to support seamless scale up
